- NZ$3.23bn
- NZ$5.76bn
- NZ$689.89m
- 64
- 75
- 62
- 73
Annual balance sheet for Ryman Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 34.4 | 20.2 | 28.3 | 27.9 | 41.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 426 | 543 | 671 | 719 | 671 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,386 | 1,659 | 2,091 | 2,205 | 1,937 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 7,677 | 9,172 | 10,966 | 12,511 | 13,084 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,376 | 6,342 | 7,532 | 7,847 | 8,666 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,301 | 2,829 | 3,435 | 4,664 | 4,418 |
| Total Liabilities & Shareholders' Equity | 7,677 | 9,172 | 10,966 | 12,511 | 13,084 |
| Total Common Shares Outstanding |